Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more
Prenetics Global Ltd - Asset Resilience Ratio
Prenetics Global Ltd (PRE) has an Asset Resilience Ratio of 5.32% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Prenetics Global Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Prenetics Global Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.46 Million | 5.32% |
| Total Liquid Assets | $10.46 Million | 5.32% |
Asset Resilience Insights
- Limited Liquidity: Prenetics Global Ltd maintains only 5.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Prenetics Global Ltd Industry Peers by Asset Resilience Ratio
Compare Prenetics Global Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Prenetics Global Ltd (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Prenetics Global Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.95% | $10.56 Million | $213.57 Million | -5.69pp |
| 2023-12-31 | 10.64% | $27.03 Million | $254.17 Million | -1.36pp |
| 2022-12-31 | 12.00% | $37.46 Million | $312.13 Million | +5.33pp |
| 2021-12-31 | 6.67% | $9.91 Million | $148.51 Million | +6.27pp |
| 2020-12-31 | 0.40% | $314.71K | $78.88 Million | -0.59pp |
| 2019-12-31 | 0.99% | $294.06K | $29.69 Million | -1.95pp |
| 2015-12-31 | 2.94% | $629.10 Million | $21.41 Billion | +1.19pp |
| 2014-12-31 | 1.75% | $390.08 Million | $22.27 Billion | -0.28pp |
| 2013-12-31 | 2.03% | $467.00 Million | $23.04 Billion | -3.26pp |
| 2012-12-31 | 5.28% | $1.21 Billion | $22.98 Billion | +1.79pp |
| 2011-12-31 | 3.49% | $798.35 Million | $22.86 Billion | -1.72pp |
| 2010-12-31 | 5.22% | $1.22 Billion | $23.36 Billion | +0.03pp |
| 2009-12-31 | 5.18% | $1.23 Billion | $23.73 Billion | +1.83pp |
| 2008-12-31 | 3.35% | $545.01 Million | $16.28 Billion | -3.09pp |
| 2007-12-31 | 6.44% | $1.03 Billion | $16.04 Billion | -3.25pp |
| 2006-12-31 | 9.69% | $1.45 Billion | $14.95 Billion | +2.67pp |
| 2005-12-31 | 7.02% | $965.21 Million | $13.74 Billion | +2.63pp |
| 2004-12-31 | 4.39% | $549.30 Million | $12.51 Billion | +0.17pp |
| 2003-12-31 | 4.22% | $460.08 Million | $10.90 Billion | -1.22pp |
| 2002-12-31 | 5.44% | $474.97 Million | $8.74 Billion | +2.50pp |
| 2001-12-31 | 2.93% | $210.15 Million | $7.17 Billion | +1.61pp |
| 2000-12-31 | 1.32% | $80.44 Million | $6.09 Billion | -- |